Defining/VBG
therapeutic/JJ
targets/NNS
by/IN
using/VBG
adenovirus/NN
:/:
blocking/VBG
NF-kappaB/NN
inhibits/VBZ
both/CC
inflammatory/JJ
and/CC
destructive/JJ
mechanisms/NNS
in/IN
rheumatoid/JJ
synovium/NN
but/CC
spares/VBZ
anti-inflammatory/JJ
mediators/NNS
./.

The/DT
role/NN
of/IN
the/DT
transcription/NN
factor/NN
NF-kappaB/NN
in/IN
the/DT
pathogenesis/NN
of/IN
rheumatoid/JJ
arthritis/NN
has/VBZ
long/RB
been/VBN
a/DT
subject/NN
of/IN
controversy/NN
./.
=====
We/PRP
used/VBD
an/DT
adenoviral/JJ
technique/NN
of/IN
blocking/VBG
NF-kappaB/NN
through/IN
overexpression/NN
of/IN
the/DT
inhibitory/JJ
subunit/NN
IkappaBalpha/NN
,/,
which/WDT
has/VBZ
the/DT
advantage/NN
that/IN
it/PRP
can/MD
be/VB
used/VBN
in/IN
the/DT
diseased/JJ
tissue/NN
itself/PRP
,/,
with/IN
>/JJR
90/CD
%/NN
of/IN
the/DT
synovial/JJ
macrophages/NNS
,/,
fibroblasts/NNS
,/,
and/CC
T/NN
cells/NNS
infected/VBN
./.
=====
We/PRP
found/VBD
that/IN
the/DT
spontaneous/JJ
production/NN
of/IN
tumor/NN
necrosis/NN
factor/NN
alpha/NN
and/CC
other/JJ
pro-inflammatory/JJ
cytokines/NNS
is/VBZ
NF-kappaB-dependent/JJ
in/IN
rheumatoid/JJ
synovial/JJ
tissue/NN
,/,
in/IN
contrast/NN
to/TO
the/DT
main/JJ
anti-inflammatory/JJ
mediators/NNS
,/,
like/IN
IL-10/NN
and/CC
-11/CD
,/,
and/CC
the/DT
IL-1/NN
receptor/NN
antagonist/NN
./.
=====
Of/IN
even/RB
more/JJR
interest/NN
,/,
IkappaBalpha/NN
overexpression/NN
inhibited/VBD
the/DT
production/NN
of/IN
matrix/NN
metalloproteinases/NNS
1/CD
and/CC
3/CD
while/IN
not/RB
affecting/VBG
their/PRP$
tissue/NN
inhibitor/NN
./.
=====
Blocking/VBG
NF-kappaB/NN
in/IN
the/DT
rheumatoid/JJ
joint/NN
thus/RB
has/VBZ
a/DT
very/RB
beneficial/JJ
profile/NN
,/,
reducing/VBG
both/CC
the/DT
inflammatory/JJ
response/NN
and/CC
the/DT
tissue/NN
destruction/NN
./.
=====
The/DT
adenoviral/JJ
technique/NN
described/VBN
here/RB
has/VBZ
widespread/JJ
applicability/NN
,/,
allowing/VBG
rapid/JJ
testing/NN
of/IN
the/DT
effects/NNS
of/IN
blocking/VBG
a/DT
potential/JJ
therapeutic/JJ
target/NN
in/IN
either/CC
cultures/NNS
of/IN
normal/JJ
cells/NNS
or/CC
in/IN
the/DT
diseased/JJ
tissue/NN
itself/PRP
./.